Actylis is a premier global manufacturer and sourcer of critical raw materials, intermediates, and specialty ingredients for a wide range of industries, including life sciences (pharmaceuticals, biopharmaceuticals, nutraceuticals), agriscience, and specialty chemicals. Formed in 2022 through the strategic combination of Aceto and other specialized companies, Actylis leverages a broad portfolio, extensive R&D capabilities, and a robust global supply chain to deliver high-quality products and customized solutions to its customers worldwide. The company focuses on innovation, quality, and customer-centric service to meet the evolving demands of complex markets.
Serves as the central hub for corporate management, strategic planning, global operations oversight, finance, and key administrative functions for Actylis's worldwide activities.
Modern office facilities designed to foster collaboration and innovation, equipped with advanced communication technology to connect with global teams and operations.
A dynamic and collaborative environment, driven by a focus on innovation, customer satisfaction, and operational excellence. Employees engage in cross-functional teamwork to support Actylis's diverse global business.
The Port Washington headquarters centralizes the leadership and strategic direction for the integrated Actylis entity, combining the strengths of multiple legacy companies into a unified global force in the specialty ingredients market.
Actylis supports a wide range of functions globally, including manufacturing, research and development, quality assurance & control, regulatory affairs, sales & marketing, supply chain management, and customer service. Their global network of offices, laboratories, and manufacturing sites ensures they can effectively serve customers across the pharmaceutical, biopharmaceutical, nutraceutical, agriscience, and specialty chemical sectors in North America, Europe, Asia, and other key international markets.
1 Tri Harbor Court
Port Washington
New York
USA
Address: Fahrenheitstraße 1, 28359 Bremen, Germany
Strengthens Actylis's presence in Europe, facilitating localized service, regulatory compliance, and efficient supply chain management for European clients.
Address: Actylis India Pvt. Ltd., Unit No. 801 & 802, 8th Floor, Crescent Business Square, Kherani Road, Opposite Sakinaka Telephone Exchange, Andheri (East), Mumbai – 400072, India
Leverages India's strong chemical and pharmaceutical manufacturing base for global supply chain and serves the rapidly growing South Asian market.
Address: Actylis (Shanghai) Co., Ltd., Room 605-606, Building 1, No. 3000 Longdong Avenue, Pudong New Area, Shanghai 201203, China
Ensures access to China's vast chemical manufacturing capabilities and serves the domestic Chinese market, while also acting as a key sourcing hub for global operations.
Address: Actylis UK Ltd., Unit 5, Moat Way, Daventry, Northamptonshire, NN11 8QL, United Kingdom
Provides specialized manufacturing capabilities within Europe, supporting Actylis's commitment to quality and regulatory compliance for critical pharma ingredients.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Actylis' leadership includes:
Actylis has been backed by several prominent investors over the years, including:
Actylis has actively strengthened its executive team over the past 12 months with key appointments in finance and commercial operations to drive its growth and integration strategy. These strategic hires bring extensive experience to their respective roles.
Discover the tools Actylis uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Actylis primarily uses the [first_initial][last_name]@actylis.com email format. This is a common corporate email structure.
[first_initial][last_name]@actylis.com
Format
gcottier@actylis.com (example for Gilles Cottier)
Example
85%
Success rate
PR Newswire • April 24, 2024
Actylis announced the expansion of its GMP manufacturing capabilities at its Daventry, UK facility. This investment enhances its capacity for producing Active Pharmaceutical Ingredients (APIs) and advanced intermediates, reinforcing its commitment to the pharmaceutical and biopharmaceutical industries....more
Actylis Website • January 9, 2024
Actylis announced the appointment of Tyrone Hornby as its new Chief Commercial Officer. Hornby will lead Actylis's global commercial strategy, sales, and marketing efforts to drive growth and expand market presence....more
Actylis Website • October 2, 2023
Actylis announced the appointment of Keith Wilkinson as its new Chief Financial Officer. Wilkinson brings extensive financial leadership experience to oversee Actylis's global finance organization and support its strategic objectives....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Actylis, are just a search away.